Some FDA-approved medical devices age more safely than others. That’s no less true of AI-enabled technologies than of any others. The agency spells out the ramifications in draft guidance issued this week. 

The devices struggle to accurately read blood-oxygen levels in patients with darker and thicker skin. The FDA hopes that changes in design and improved clinical trials will improve clinical efficacy.

The National Mammography Quality Assurance Advisory Committee provides guidance and recommendations related to the standards by which facilities are regulated. 

Gov. Maura Healey has until Jan. 9 to pass the act into law or use her veto powers. The bill passed the state Senate on Dec. 30. 

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Hospital boards of trustees should be grilling their CEOs about AI. 

Watch for healthcare AI to increase its footprint in the patient-safety domain over the coming year. 

The Hartford, Connecticut-based payer filed the complaint in Florida Middle District Court, alleging the actions defrauded it of "tens of millions."